col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

179 Results       Page 1

Springer-Verlag: Journal of Thrombosis and Thrombolysis
  original article Date Title Authors   All Authors
1 [GO] 2023―May―23 Significance of heparin induced thrombocytopenia (HIT) in COVID-19: a systematic review and meta-analysis Mehrdad Rostami, Hassan Mansouritorghabeh
2 [GO] 2023―Jan―18 Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis Marco Zuin, Stefano Barco, George Giannakoulas, Matthias M Engelen, Lukas Hobohm, Luca Valerio, et al. (+4)
3 [GO] 2023―Jan―18 Thrombotic outcomes in patients in a large clinical enterprise following COVID-19 vaccination William M. Patterson, Brady D. Greene, Leben Tefera, James Bena, Alex Milinovich, Neil Mehta, et al. (+4)
4 [GO] 2022―Dec―24 Nasopharyngeal viral load at admission is not an independent predictor of thromboembolic complications in unvaccinated COVID-19 hospitalized patients. Narda Ontiveros, Adolfo Del Bosque-Aguirre, Mauricio Gonzalez-Urquijo, David E. Hinojosa Gonzalez, Michel Fernando Martinez-Resendez, Luis Schang, Mario Alejandro Fabiani
5 [GO] 2022―Dec―17 Comprehensive collection of COVID-19 related prosthetic valve failure: a systematic review Theresa K. Trieu, Kade Birkeland, Asher Kimchi, Ilan Kedan
6 [GO] 2022―Dec―14 Association between thromboembolic events and COVID-19 infection within 30 days: a case-control study among a large sample of adult hospitalized patients in the United States, March 2020-June 2021 Ya-Lin A. Huang, Hussain Yusuf, Alys Adamski, Joy Hsu, James Baggs, Rehab Auf, et al. (+9)
7 [GO] 2022―Nov―19 Incidence and outcomes of splanchnic vein thrombosis after diagnosis of COVID-19 or COVID-19 vaccination: a systematic review and meta-analysis Xiaojie Zheng, Fangbo Gao, Le Wang, Yao Meng, Walter Ageno, Xingshun Qi
8 [GO] 2022―Nov―13 Targeted genetic analysis unveils novel associations between ACE I/D and APO T158C polymorphisms with D-dimer levels in severe COVID-19 patients with pulmonary embolism Giuseppe Fiorentino, Giuditta Benincasa, Antonietta Coppola, Monica Franzese, Anna Annunziata, Ornella Affinito, et al. (+2)
9 [GO] 2022―Sep―19 Correction: Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study Steve Deitelzweig, Xuemei Luo, Jennifer L. Nguyen, Deepa Malhotra, Birol Emir, Cristina Russ, et al. (+7)
10 [GO] 2022―Sep―19 SARS-CoV-2 antibody research in patients with unprovoked pulmonary embolism in COVID-19 pandemic period Ersan Atahan, Emine Karabul, Ruveyda Akcin, Buket Caliskaner Ozturk, Aysegul Gencer, Bekir Kocazeybek
11 [GO] 2022―Aug―03 Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials Eros Pilia, Alessandro Belletti, Stefano Fresilli, Gabriele Finco, Giovanni Landoni
12 [GO] 2022―Jul―26 High levels of von Willebrand factor with reduced specific activities in hospitalized patients with or without COVID-19 Monica Bray, Melda A. Guzel, Fong Lam, Andrew Yee, Miguel A. Cruz, Rolando E. Rumbaut
13 [GO] 2022―Jun―28 Limb ischemia due to spontaneous heparin-induced thrombocytopenia as the primary presentation of acute COVID-19 infection Eileen Shiuan, Deva Sharma, E. Wesley Ely, Nikil Moodabagil, Benjamin F. Tillman
14 [GO] 2022―Jun―28 “Lockdown-thrombosis”-an unexpected problem of the COVID-19 pandemic? Chaozer Er, Jing Yuan Tan, Chuen Wen Tan, Hartirathpal Kaur, May Anne Cheong, Lai Heng Lee, Heng Joo Ng
15 [GO] 2022―Jun―10 Major hemorrhage and mortality in COVID-19 patients on therapeutic anticoagulation for venous thromboembolism Martin R. Prince, Hreedi Dev, Elizabeth G. Lane, Daniel J. Margolis, Maria T. DeSancho
16 [GO] 2022―Jun―02 Metformin therapy in COVID-19: inhibition of NETosis Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
17 [GO] 2022―May―17 Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum Geoffrey D Barnes, Allison Burnett, Arthur Allen, Jack Ansell, Marilyn Blumenstein, Nathan P Clark, et al. (+10)
18 [GO] 2022―Apr―30 Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study Steve Deitelzweig, Xuemei Luo, Jennifer L. Nguyen, Deepa Malhotra, Birol Emir, Cristina Russ, et al. (+7)
19 [GO] 2022―Mar―04 Characteristics and comparisons of acute stroke in “recovered" to “active COVID-19 and “pre-pandemic” in Qatar database Naveed Akhtar, Fatma Abid, Rajvir Singh, Saadat Kamran, Yahia Imam, Salman Al Jerdi, et al. (+8)
20 [GO] 2022―Feb―14 A systematic review of vaccine-induced thrombotic thrombocytopenia in individuals who received COVID-19 adenoviral-vector-based vaccines Mostafa H. Elberry, Hussien Ahmed H. Abdelgawad, Aboalmagd Hamdallah, Walid Shaban Abdella, Ahmed Sayed Ahmed, Hazem S. Ghaith, Ahmed Negida
21 [GO] 2022―Feb―03 Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study-Reply to comment from Muzaffar et al. Bingwen Eugene Fan, Yew Woon Chia, Gek Hsiang Lim, Chwee Fang Bok, Shiun Woei Wong
22 [GO] 2022―Jan―29 Efficacy and safety of app-based remote warfarin management during COVID-19-related lockdown: a retrospective cohort study Shaojun Jiang, Meina Lv, Zhiwei Zeng, Zongwei Fang, Mingrong Chen, Jiafen Qian, et al. (+3)
23 [GO] 2022―Jan―18 Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes Abira Usman, Kevin P. Bliden, Alastair Cho, Naval Walia, Christophe Jerjian, Arvind Singh, et al. (+4)
24 [GO] 2021―Dec―14 Complement system component dysregulation is a distinctive feature of COVID-19 disease: a prospective and comparative analysis of patients admitted to the emergency department for suspected COVID-19 disease Nadine Gauchel, Marina Rieder, Krystin Krauel, Isabella Goller, Maren Jeserich, Ulrich Salzer, et al. (+12)
25 [GO] 2021―Nov―20 Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study Syed Nabeel Muzaffar, Suhail Sarwar Siddiqui, Afzal Azim
26 [GO] 2021―Nov―05 Brain venography performance following the pause of Ad.26.COV2.S COVID-19 vaccine administration Clayton V. Long, Jonathan D. Clemente, Sam Singh, Dale Strong, Jeremy B. Rhoten, Tanushree Prasad, Andrew W. Asimos
27 [GO] 2021―Nov―04 International COVID-19 biomarkers colloquium Richard C. Becker, Diana A. Gorog
28 [GO] 2021―Nov―01 A comprehensive review of vascular complications in COVID-19 Yogesh Acharya, Aqeel Alameer, Gavin Calpin, Maha Alkhattab, Sherif Sultan
29 [GO] 2021―Oct―28 The role of lipoprotein(a) in coronavirus disease 2019 (COVID-19) with relation to development of severe acute kidney injury Giuseppe Lippi, Ivan Szergyuk, Maria Helena Santos de Oliveira, Stefanie W. Benoit, Justin L. Benoit, Emmanuel J. Favaloro, Brandon Michael Henry
30 [GO] 2021―Oct―27 Pulmonary embolism in patients with COVID-19 pneumonia on adequate oral anticoagulation Giuseppe Di Tano, Meghi Dede, Irene Pellicelli, Enrico Martinelli, Luigi Moschini, Elva Calvaruso, Gian Battista Danzi
31 [GO] 2021―Oct―23 Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy Rossella Cacciola, Elio Gentilini Cacciola, Veronica Vecchio, Emma Cacciola
32 [GO] 2021―Sep―28 Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study Bingwen Eugene Fan, Kollengode Ramanathan, Christina Lai Lin Sum, Dheepa Christopher, Stephrene Seok Wei Chan, Gek Hsiang Lim, et al. (+13)
33 [GO] 2021―Sep―23 COVID-19 risk index (CRI): a simple and validated emergency department risk score that predicts mortality and the need for mechanical ventilation Mohamad Raad, Sarah Gorgis, Chelsea Abshire, Monica Yost, Mohammed F Dabbagh, Omar Chehab, et al. (+8)
34 [GO] 2021―Sep―22 Patterns of vascular access device use and thrombosis outcomes in patients with COVID-19: a pilot multi-site study of Michigan hospitals Jonathan Sebolt, Julian Buchinger, Sushant Govindan, Qisu Zhang, Megan O’Malley, Vineet Chopra
35 [GO] 2021―Sep―15 Prophylactic versus therapeutic anticoagulation for survival of patients with COVID-19 on steroid Toshiki Kuno, Matsuo So, Mai Takahashi, Natalia N. Egorova
36 [GO] 2021―Sep―14 Immature platelets in patients with Covid-19: association with disease severity Amir Cohen, Emanuel Harari, Ella Yahud, Michal Cipok, Gabriel Bryk, Nili Karp Lador, et al. (+3)
37 [GO] 2021―Sep―12 Potential antiviral properties of antiplatelet agents against SARS-CoV-2 infection: an in silico perspective Mohammed A. Abosheasha, Afnan H. El-Gowily, Abdo A. Elfiky
38 [GO] 2021―Sep―08 Direct oral anticoagulant plasma levels in hospitalized COVID-19 patients treated with dexamethasone Nicola Potere, Matteo Candeloro, Ettore Porreca, Stefano Marinari, Camilla Federici, Raffaella Auciello, Marcello Di Nisio
39 [GO] 2021―Aug―26 One-year outcomes of patients with ST-segment elevation myocardial infarction during the COVID-19 pandemic Kailun Phua, Nicholas W. S. Chew, Vincent Sim, Audrey A. Zhang, Saurabh Rastogi, Pipin Kojodjojo, et al. (+18)
40 [GO] 2021―Aug―19 Evaluation of a patient specific, targeted-intensity pharmacologic thromboprophylaxis protocol in hospitalized patients with COVID-19 Julie E. Farrar, Toby C. Trujillo, Scott W. Mueller, Lyra Beltran, Cecilia Nguyen, Kathryn Hassell, Tyree H. Kiser
41 [GO] 2021―Aug―17 Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor’s page series Richard C. Becker
42 [GO] 2021―Aug―04 COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles Richard C. Becker, Travis Sexton, Susan Smyth
43 [GO] 2021―Jul―16 Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: Results from a Spanish multicenter registry (BIOCOVID-Spain study) Luis García de Guadiana-Romualdo, Daniel Morell-García, Emmanuel J. Favaloro, Juan A. Vílchez, Josep M. Bauça, María J. Alcaide Martín, et al. (+53)
44 [GO] 2021―Jul―14 Evaluation of coagulation status using clot waveform analysis in general ward patients with COVID-19 Junko Ichikawa, Ryouta Okazaki, Tomoki Fukuda, Takuya Ono, Motonao Ishikawa, Makiko Komori
45 [GO] 2021―Jul―13 Venous and arterial thromboembolic disease in COVID-19 J. ten Berg
46 [GO] 2021―Jul―02 U shape association of hemoglobin level with in-hospital mortality for COVID-19 patients Toshiki Kuno, Matsuo So, Mai Takahashi, Natalia N. Egorova
47 [GO] 2021―Jun―26 Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS-COV-2 infection Maurizio Fattorutto, Yves Bouckaert, Jonathan Brauner, Stéphane Franck, Fabrice Bouton, Danielle Heuse, et al. (+2)
48 [GO] 2021―Jun―23 Routine screening for pulmonary embolism in COVID-19 patients at the emergency department: impact of D-dimer testing followed by CTPA Daniël A. Korevaar, Ilayda Aydemir, Maartje W. Minnema, Kaoutar Azijli, Ludo F. Beenen, Jarom Heijmans, et al. (+8)
49 [GO] 2021―Jun―19 External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19 Mark Goldin, Stephanie K. Lin, Nina Kohn, Michael Qiu, Stuart L. Cohen, Matthew A. Barish, et al. (+11)
50 [GO] 2021―Jun―17 Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19 Mariana Corrochano, René Acosta-Isaac, Sergi Mojal, Sara Miqueleiz, Diana Rodriguez, María Ángeles Quijada-Manuitt, et al. (+7)
51 [GO] 2021―Jun―10 Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19 Marco G. Mennuni, Roberta Rolla, Leonardo Grisafi, Enrico G. Spinoni, Andrea Rognoni, Veronica Lio, et al. (+10)
52 [GO] 2021―Jun―02 Association between previous anticoagulant use and mortality among hospitalized patients with COVID-19 Oktay Gülcü, Emrah Aksakal, Selim Aydemir, Remziye Doğan, İbrahim Saraç, Sidar Şiyar Aydın, et al. (+4)
53 [GO] 2021―Jun―01 Prior use of anticoagulation is associated with a better survival in COVID-19 A. G. Buenen, Marijn Sinkeldam, Martje L. Maas, Martha Verdonschot, Peter C. Wever
54 [GO] 2021―May―29 Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial ınfarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial ınfarction registry) Tuncay Kiris, Eyüp Avci, Tuba Ekin, Didar Elif Akgün, Mücahit Tiryaki, Arafat Yidirim, et al. (+14)
55 [GO] 2021―May―28 Incidence of thrombotic complications in COVID-19 William J. Jenner, Diana A. Gorog
56 [GO] 2021―May―28 Transient endothelial injury and release of lupus anticoagulant in COVID-19 Antonin Trimaille, Benjamin Marchandot, Walid Oulehri, Adrien Carmona, Olivier Vollmer, Vincent Poindron, et al. (+6)
57 [GO] 2021―May―28 Increased incidence of massive hemorrhage at uncommon sites after initiation of systemic anticoagulation in critically ill patients with coronavirus disease 2019 (COVID-19) infection Salwa A. Koubaissi, Michella Abi Zeid Daou, Rayan Mohamad, Ahmad Husari
58 [GO] 2021―May―22 International COVID-19 thrombosis biomarkers colloquium: COVID-19 diagnostic tests Paul A. Gurbel, Udaya S. Tantry, Robert F. Storey
59 [GO] 2021―May―21 Screening for venous thromboembolism in patients with COVID-19 Christophe Vandenbriele, Diana A. Gorog
60 [GO] 2021―May―14 Venous thromboembolism in non-COVID-19 population during the pandemic: a nationwide multicenter retrospective survey Cheng Qian, Xiao Lyu, Hai-Dong Zhu, Yi Zhang, Rui-Jie Du, Rui Li, et al. (+2)
61 [GO] 2021―May―12 ICODE: the international COVID-19 thrombosis biomarkers colloquium-novel soluble biomarkers: circulating cell-free nucleic acids and other molecules Krystin Krauel, Daniel Duerschmied
62 [GO] 2021―May―10 Antiphospholipid antibodies in critically ill COVID-19 patients with thromboembolism: cause of disease or epiphenomenon? Vittorio Pavoni, Lara Gianesello, Andrew Horton
63 [GO] 2021―May―08 The characteristics and outcomes of critically Ill patients with COVID-19 who received systemic thrombolysis for presumed pulmonary embolism: an observational study Matsuo So, David J. Steiger, Mai Takahashi, Natalia N. Egorova, Toshiki Kuno
64 [GO] 2021―May―03 Prevalence and consequences of empiric anticoagulation for venous thromboembolism in patients hospitalized for COVID-19: a cautionary tale Daniel L. Eisenson, Oluwafemi P. Owodunni, Brandyn D. Lau, Mujan Varasteh Kia, Peggy S. Kraus, Christine G. Holzmueller, et al. (+3)
65 [GO] 2021―Apr―28 Correction to: Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation Elvira Grandone, Giovanni Tiscia, Raffaele Pesavento, Antonio De Laurenzo, Davide Ceccato, Maria Teresa Sartori, et al. (+9)
66 [GO] 2021―Apr―28 Massive intraperitoneal hemorrhage in patients with COVID-19: a case series Vahid Reisi-Vanani, Zahra Lorigooini, Mohamad Ali Dayani, Mehrandokht Mardani, Fereidoun Rahmani
67 [GO] 2021―Apr―26 Impact of the pandemic of COVID-19 on emergency attendance for stroke and acute myocardial infarction in Beijing, China Yiqun Wu, Fei Chen, Zhaobin Sun, Yingxian Zhang, Yafang Song, Wuwei Feng, et al. (+3)
68 [GO] 2021―Apr―22 Second wave of the COVID-19 pandemic: D-dimer levels are not so high anymore Angelo Porfidia, Enrica Porceddu, Rosa Talerico, Massimo Montalto, Francesco Landi, Roberto Pola
69 [GO] 2021―Apr―22 Incidence of venous thromboembolism in patients with non-hematological cancer admitted for COVID-19 at a third-level hospital in Madrid Diana Paredes-Ruiz, Covadonga Gómez-Cuervo, Carlos Gómez-Martín, Ángel Sánchez-Guerrero, Jesús González-Olmedo, Flora López-López, et al. (+8)
70 [GO] 2021―Apr―17 Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19 A Marco, P Marco
71 [GO] 2021―Apr―12 Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation Elvira Grandone, Giovanni Tiscia, Raffaele Pesavento, Antonio De Laurenzo, Davide Ceccato, Maria Teresa Sartori, et al. (+9)
72 [GO] 2021―Apr―12 Abnormal immunothrombosis and lupus anticoagulant in a catastrophic COVID-19 recalling Asherson’s syndrome Luca Roncati, Lorenzo Corsi, Giuseppe Barbolini
73 [GO] 2021―Apr―07 COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography Cheryl L. Maier, Tania Sarker, Fania Szlam, Roman M. Sniecinski
74 [GO] 2021―Apr―07 Bedside thromboelastography to rapidly assess the pharmacodynamic response of anticoagulants and aspirin in COVID-19: evidence of inadequate therapy in a predominantly minority population Paul A. Gurbel, Kevin P. Bliden, Amit Rout, Nicole Rapista, Naval Walia, Rahul Chaudhary, et al. (+4)
75 [GO] 2021―Apr―04 Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta-analysis Chia Siang Kow, Syed Shahzad Hasan
76 [GO] 2021―Apr―01 Acute limb ischemia in a patient with Covid-19 pneumonia: a case report Ulfah Kartikasari, Susanthy Djajalaksana, Heny Martini
77 [GO] 2021―Mar―31 Ovarian vein thrombosis after coronavirus disease (COVID-19) mimicking acute abdomen: two case reports Merzouk Fatimazahra, Mahassine El Harras, Ilham Bensahi, Meriem Kassimi, Sara Oualim, Amal Elouarradi, et al. (+2)
78 [GO] 2021―Mar―17 CHA2DS2-VASc score and modified CHA2DS2-VASc score can predict mortality and intensive care unit hospitalization in COVID-19 patients Ramazan Gunduz, Bekir Serhat Yildiz, Ibrahim Halil Ozdemir, Nurullah Cetin, Mehmet Burak Ozen, Eren Ozan Bakir, et al. (+2)
79 [GO] 2021―Mar―12 Can a modified-simplified pulmonary embolism severity index (m-sPESI) be used to predict the need for intensive care in hospitalized COVID-19 patients? Ahmet Kagan As, Burak Erdolu, Burak Duman, Elif Yazgan, Cuneyt Eris, Ufuk Aydin, et al. (+3)
80 [GO] 2021―Mar―09 Medical publishing during the COVID-19 pandemic: then and now Richard C. Becker, Christoph Bode
81 [GO] 2021―Mar―06 Outpatient management of chronic warfarin therapy at a pharmacist-run anticoagulation clinic during the COVID-19 pandemic Rebecca Cope, Briann Fischetti, Nourhan Eladghm, Mahy Elaskandrany, Nardine Karam
82 [GO] 2021―Mar―05 Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19 Dimitrios Giannis, Matthew A. Barish, Mark Goldin, Stuart L. Cohen, Nina Kohn, Eugenia Gianos, et al. (+6)
83 [GO] 2021―Mar―01 Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 Marco G. Mennuni, Giulia Renda, Leonardo Grisafi, Andrea Rognoni, Crizia Colombo, Veronica Lio, et al. (+23)
84 [GO] 2021―Mar―01 Major bleeding complications in critically ill patients with COVID-19 pneumonia Anne Godier, Darless Clausse, Simon Meslin, Myriame Bazine, Elodie Lang, Florian Huche, et al. (+2)
85 [GO] 2021―Mar―01 ST-segment elevation in patients with COVID-19: a systematic review Carlos Diaz-Arocutipa, Javier Torres-Valencia, Jose Saucedo-Chinchay, Cecilia Cuevas
86 [GO] 2021―Feb―19 Incidence of venous thromboembolism among patients with severe COVID-19 requiring mechanical ventilation compared to other causes of respiratory failure: a prospective cohort study José Augusto Santos Pellegrini, Tatiana Helena Rech, Patrícia Schwarz, Ana Cláudia Tonelli de Oliveira, Tarsila Vieceli, Rafael Barberena Moraes, et al. (+2)
87 [GO] 2021―Feb―18 Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review William J. Jenner, Rahim Kanji, Saeed Mirsadraee, Ying X. Gue, Susanna Price, Sanjay Prasad, Diana A. Gorog
88 [GO] 2021―Feb―01 Association of chronic anticoagulant and antiplatelet use on disease severity in SARS-COV-2 infected patients Gwendolyn Ho, Jennifer R. Dusendang, Julie Schmittdiel, Juraj Kavecansky, Jahan Tavakoli, Ashok Pai
89 [GO] 2021―Jan―30 Pulmonary venous thrombosis in a patient with COVID-19 infection Ahmed K. Pasha, Alejandro Rabinstein, Robert D. McBane
90 [GO] 2021―Jan―28 Nonadministration of pharmacologic venous thromboembolism prophylaxis is less common in hospitalized patients with COVID-19 Mujan Varasteh Kia, Brandyn D. Lau, Oluwafemi P. Owodunni, Peggy S. Kraus, Christine G. Holzmueller, Deborah B. Hobson, et al. (+3)
91 [GO] 2021―Jan―27 COVID-19 and its sequelae: a platform for optimal patient care, discovery and training Richard C. Becker
92 [GO] 2021―Jan―15 Association of ABO blood group type with cardiovascular events in COVID-19 Victor Nauffal, Aditya Achanta, Samuel Z. Goldhaber, Gregory Piazza
93 [GO] 2021―Jan―15 SARS-CoV-2 infection and thrombotic complications: a narrative review Iraklis C. Moschonas, Alexandros D. Tselepis
94 [GO] 2021―Jan―03 A case of thrombotic thrombocytopenic purpura associated with COVID-19 Davide Nicolotti, Elena G. Bignami, Sandra Rossi, Antonella Vezzani
95 [GO] 2021―Jan―02 Awareness of thrombotic disease during lockdown: an unusual consequence of the COVID-19 pandemic Matthaios Speletas
96 [GO] 2021―Jan―02 Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox? Franco Ruberto, Antonio Chistolini, Mariaignazia Curreli, Giacomo Frati, Antonino G. M. Marullo, Giuseppe Biondi-Zoccai, et al. (+10)
97 [GO] 2021―Jan―02 Ongoing trials on COVID-19 treatments: please, don’t forget Venous Thromboembolism! Marco Zuin, Giovanni Zuliani, Gianluca Rigatelli, Loris Roncon
98 [GO] 2021―Jan―01 Pulmonary thrombosis in Covid-19: before, during and after hospital admission Maria Vlachou, Anja Drebes, Luciano Candilio, Deshan Weeraman, Naheed Mir, Nick Murch, et al. (+2)
99 [GO] 2020―Nov―17 Ecchymosis in critical coronavirus disease 2019 (COVID-19) patient in Tangerang, Indonesia: a case report Allen Widysanto, T. D. Wahyuni, L. H. Simanjuntak, S. Sunarso, S. S. Siahaan, H. Haryanto, et al. (+3)
100 [GO] 2020―Nov―16 Clinical features of patients with acute coronary syndrome during the COVID-19 pandemic Kensuke Matsushita, Sebastien Hess, Benjamin Marchandot, Chisato Sato, Dinh Phi Truong, Ngoc Thanh Kim, et al. (+4)
101 [GO] 2020―Nov―11 Increased interest in acute pulmonary embolism in Italy during the COVID-19 pandemic: a google trends-based analysis Loris Roncon, Marco Zuin, Stefano Barco, Giovanni Zuliani, Stavros V Konstantinides
102 [GO] 2020―Nov―07 Lupus anticoagulant and mortality in patients hospitalized for COVID-19 Carmine Gazzaruso, Giuseppe Mariani, Carolina Ravetto, Laura Malinverni, Elena Tondelli, Maria Cerrone, et al. (+5)
103 [GO] 2020―Nov―07 Delayed catastrophic thrombotic events in young and asymptomatic post COVID-19 patients Bingwen Eugene Fan, Thirugnanam Umapathi, Karen Chua, Yew Woon Chia, Shiun Woei Wong, Glenn Wei Leong Tan, et al. (+4)
104 [GO] 2020―Nov―06 Evidence of systemic endothelial injury and microthrombosis in hospitalized COVID-19 patients at different stages of the disease Domenico G. Della Rocca, Michele Magnocavallo, Carlo Lavalle, Jorge Romero, Giovanni B. Forleo, Nicola Tarantino, et al. (+6)
105 [GO] 2020―Nov―05 Neutrophil extracellular traps and thrombosis in COVID-19 Yu Zuo, Melanie Zuo, Srilakshmi Yalavarthi, Kelsey Gockman, Jacqueline A. Madison, Hui Shi, et al. (+5)
106 [GO] 2020―Nov―03 Combining lung ultrasound and Wells score for diagnosing pulmonary embolism in critically ill COVID-19 patients Viviane Zotzmann, Corinna N. Lang, Tobias Wengenmayer, Xavier Bemtgen, Bonaventura Schmid, Katharina Mueller-Peltzer, et al. (+4)
107 [GO] 2020―Oct―24 COVID-19 associated coagulopathy in critically ill patients: A hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis Bingwen Eugene Fan, Jensen Ng, Stephrene Seok Wei Chan, Dheepa Christopher, Allison Ching Yee Tso, Li Min Ling, et al. (+9)
108 [GO] 2020―Oct―17 Rotational thromboelastometry results are associated with care level in COVID-19 Lou M. Almskog, Agneta Wikman, Jonas Svensson, Michael Wanecek, Matteo Bottai, Jan van der Linden, Anna Ågren
109 [GO] 2020―Oct―15 Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19 Xin Wang, Kamal Kant Sahu, Jan Cerny
110 [GO] 2020―Oct―15 Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 Vittorio Pavoni, Lara Gianesello
111 [GO] 2020―Oct―07 Occurrence of pulmonary embolism related to COVID-19 Marie Hauguel-Moreau, Mostafa El Hajjam, Quentin De Baynast, Antoine Vieillard-Baron, Anne-Sophie Lot, Thierry Chinet, et al. (+7)
112 [GO] 2020―Oct―07 Filter clotting with continuous renal replacement therapy in COVID-19 Paul Endres, Rachel Rosovsky, Sophia Zhao, Scott Krinsky, Shananssa Percy, Omer Kamal, et al. (+13)
113 [GO] 2020―Oct―04 The experience of Hamad General Hospital collaborative anticoagulation clinic in Qatar during the COVID-19 pandemic Ibtihal Abdallah, Asma Eltahir, Liam Fernyhough, Ahmed El-Bardissy, Rana Ahmed, Mohammed Abdulgelil, et al. (+8)
114 [GO] 2020―Oct―04 Thromboelastography findings in critically ill COVID-19 patients Nouran Salem, Bassam Atallah, Wasim S. El Nekidy, Ziad G. Sadik, Woosup Michael Park, Jihad Mallat
115 [GO] 2020―Sep―30 Immature platelets in patients hospitalized with Covid-19 Amir Cohen, Emanuel Harari, Michal Cipok, Avishag Laish-Farkash, Gabriel Bryk, Ella Yahud, et al. (+5)
116 [GO] 2020―Sep―26 Coronavirus disease 2019 (COVID-19) in patients with systemic autoimmune diseases or vasculitis: radiologic presentation Azadeh Eslambolchi, Leila Aghaghazvini, Ali Gholamrezanezhad, Hoda Kavosi, Amir Reza Radmard
117 [GO] 2020―Sep―24 Risk factors for intracerebral hemorrhage in patients with COVID-19 Kara R. Melmed, Meng Cao, Siddhant Dogra, Ruina Zhang, Shadi Yaghi, Ariane Lewis, et al. (+8)
118 [GO] 2020―Sep―22 Correction to: Acute pulmonary embolism in COVID-19 related hypercoagulability Lorenzo Cerruti, Francesca Boscaro, Francesco Poletto, Elena Campello, Luca Spiezia, Paolo Simioni
119 [GO] 2020―Sep―12 Dynamic changes in fibrinogen and D-dimer levels in COVID-19 patients on nafamostat mesylate Itsuki Osawa, Koh Okamoto, Mahoko Ikeda, Amato Otani, Yuji Wakimoto, Marie Yamashita, et al. (+8)
120 [GO] 2020―Sep―10 Pulmonary Embolism Response Team activation during the COVID-19 pandemic in a New York City Academic Hospital: a retrospective cohort analysis Benjamin Kwok, Shari B. Brosnahan, Nancy E. Amoroso, Ronald M. Goldenberg, Brooke Heyman, James M. Horowitz, et al. (+5)
121 [GO] 2020―Sep―10 Diagnosis, management, and outcomes of venous thromboembolism in COVID-19 positive patients: a role for direct anticoagulants? Charalampos Kartsios, Anand Lokare, Husam Osman, Damian Perrin, Shahzad Razaq, Namrah Ayub, et al. (+2)
122 [GO] 2020―Sep―05 Markers of coagulation dysfunction and inflammation in diabetic and non-diabetic COVID-19 Seshadri Reddy Varikasuvu, Saurabh Varshney, Naveen Dutt
123 [GO] 2020―Sep―03 Anticipating the long-term cardiovascular effects of COVID-19 Richard C. Becker
124 [GO] 2020―Sep―03 Differentiating biochemical from clinical heparin resistance in COVID-19 Ton Lisman, Jecko Thachil
125 [GO] 2020―Aug―24 Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection Fergal McGlynn, Jennifer McGrath, Chithra Varghese, Barbara Ryan, Johnny McHugh, Arabella Fahy, Helen Enright
126 [GO] 2020―Aug―20 Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis Mohamed Abdel-Maboud, Amr Menshawy, Ahmed Elgebaly, Eshak I. Bahbah, Gehad El Ashal, Ahmed Negida
127 [GO] 2020―Aug―19 Impact of COVID-19 on monitoring of therapeutic unfractionated heparin Sarah K. Adie, Nicholas Farina
128 [GO] 2020―Aug―18 High prevalence of early asymptomatic venous thromboembolism in anticoagulated COVID-19 patients hospitalized in general wards Sylvain Le Jeune, Jaehyo Suhl, Ruben Benainous, François Minvielle, Christine Purser, Farid Foudi, et al. (+2)
129 [GO] 2020―Aug―18 Anticoagulant treatment in COVID-19: a narrative review Vincenzo Carfora, Giorgio Spiniello, Riccardo Ricciolino, Marco Di Mauro, Marco Giuseppe Migliaccio, Filiberto Fausto Mottola, et al. (+2)
130 [GO] 2020―Aug―14 Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis Chiara Kessler, Hans Stricker, Daniela Demundo, Luigia Elzi, Rita Monotti, Giorgia Bianchi, et al. (+13)
131 [GO] 2020―Aug―13 In vivo demonstration of microvascular thrombosis in severe COVID-19 Douglas Alexandre do Espírito Santo, Anna Cristina Bertoldi Lemos, Carlos Henrique Miranda
132 [GO] 2020―Aug―13 Safety of intermediate dose of low molecular weight heparin in COVID-19 patients Massimo Mattioli, Devis Benfaremo, Mauro Mancini, Luciano Mucci, Paola Mainquà, Antonio Polenta, et al. (+7)
133 [GO] 2020―Aug―12 Can fibrinolytic therapy be clinically useful in severe pneumonia caused by COVID-19? Rafael Bornstein, José Antonio Páramo
134 [GO] 2020―Aug―11 Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019 Yoshihiko Ogawa, Toshihiko Nagata, Taisuke Akiyama, Koji Nishida, Junji Kumasawa, Michihiko Kohno, et al. (+2)
135 [GO] 2020―Aug―06 Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19 Yang Liu, Weibo Gao, Wei Guo, Yang Guo, Maojing Shi, Guiying Dong, et al. (+3)
136 [GO] 2020―Aug―05 Long lasting hypercoagulability after subclinical COVID-19 Paolo Ferroli, Chiara Villa, Andrea Ciuffi, Guido Gubertini, Morgan Broggi
137 [GO] 2020―Aug―03 Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis Syed Shahzad Hasan, Sam Radford, Chia Siang Kow, Syed Tabish Razi Zaidi
138 [GO] 2020―Jul―30 Concerns for management of STEMI patients in the COVID-19 era: a paradox phenomenon Panayotis K. Vlachakis, Anastasios Tentolouris, Ioannis Kanakakis
139 [GO] 2020―Jul―22 COVID-19-associated vasculitis and vasculopathy Richard C. Becker
140 [GO] 2020―Jul―21 Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic Benjamin Marchandot, Antonin Trimaille, Anais Curtiaud, Kensuke Matsushita, Laurence Jesel, Olivier Morel
141 [GO] 2020―Jul―16 COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness Fenghe Du, Bao Liu, Shuyang Zhang
142 [GO] 2020―Jul―16 How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report Ezio Zanon, Samantha Pasca, Elena Campello, Luca Spiezia, Roberto Vettor, Paolo Simioni
143 [GO] 2020―Jul―13 COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature Ying-Kiat Tan, Claire Goh, Aloysius S. T. Leow, Paul A. Tambyah, Alicia Ang, Eng-Soo Yap, et al. (+5)
144 [GO] 2020―Jul―13 Impact of the COVID-19 pandemic on hyperacute stroke treatment: experience from a comprehensive stroke centre in Singapore Prakash R. Paliwal, Benjamin Y. Q. Tan, Aloysius S. T. Leow, Sunny Sibi, Daniel W. P. Chor, Amanda X. Y. Chin, et al. (+21)
145 [GO] 2020―Jul―11 Thrombotic circuit complications during venovenous extracorporeal membrane oxygenation in COVID-19 Xavier Bemtgen, Viviane Zotzmann, Christoph Benk, Jonathan Rilinger, Katrin Steiner, Alexander Asmussen, et al. (+4)
146 [GO] 2020―Jul―09 Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients Yan Zhang, Wei Cao, Wei Jiang, Meng Xiao, Yongzhe Li, Ning Tang, et al. (+5)
147 [GO] 2020―Jul―09 Aortic thrombus in patients with severe COVID-19: review of three cases María de Carranza, Danilo-Eduardo Salazar, Jesús Troya, Roberto Alcázar, Cristina Peña, Esther Aragón, et al. (+3)
148 [GO] 2020―Jul―06 Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory? Vera Paar, Bernhard Wernly, Zhichao Zhou, Lukas J. Motloch, Uta C. Hoppe, Alexander Egle, Michael Lichtenauer
149 [GO] 2020―Jul―05 COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection? Ritwick Mondal, Durjoy Lahiri, Shramana Deb, Deebya Bandyopadhyay, Gourav Shome, Sukanya Sarkar, et al. (+4)
150 [GO] 2020―Jul―03 Anticoagulation clinic drive-up service during COVID-19 pandemic in Qatar Eman Alhmoud, Osama Abdelsamad, Ezeldin Soaly, Rasha El Enany, Hazem Elewa
151 [GO] 2020―Jul―02 Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19 Marina Rieder, Isabella Goller, Maren Jeserich, Niklas Baldus, Luisa Pollmeier, Luisa Wirth, et al. (+7)
152 [GO] 2020―Jul―01 Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis B. Mestre-Gómez, R. M. Lorente-Ramos, J. Rogado, A. Franco-Moreno, B. Obispo, D. Salazar-Chiriboga, et al. (+8)
153 [GO] 2020―Jun―30 DVT incidence and risk factors in critically ill patients with COVID-19 Shujing Chen, Dingyu Zhang, Tianqi Zheng, Yongfu Yu, Jinjun Jiang
154 [GO] 2020―Jun―29 Impact of Coronavirus Disease 2019 outbreak on acute coronary syndrome admissions: four weeks to reverse the trend Marie Hauguel-Moreau, Rémy Pillière, Giulio Prati, Sébastien Beaune, Thomas Loeb, Simon Lannou, et al. (+5)
155 [GO] 2020―Jun―28 Pharmacologic therapeutic options for thromboprophylaxis in COVID-19 Chia Siang Kow, Syed Shahzad Hasan
156 [GO] 2020―Jun―22 Correction to: Heparin resistance in COVID-19 patients in the intensive care unit D. White, S. MacDonald, T. Bull, M. Hayman, D. de Monteverde-Robb, D. Sapsford, et al. (+5)
157 [GO] 2020―Jun―10 Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis Bilian Yu, Xin Li, Jin Chen, Mingqi Ouyang, Hong Zhang, Xinge Zhao, et al. (+7)
158 [GO] 2020―Jun―09 Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19 Mario Bautista-Vargas, Fabio Bonilla-Abadía, Carlos A. Cañas
159 [GO] 2020―Jun―09 Incidence and consequences of systemic arterial thrombotic events in COVID-19 patients Estefanía Cantador, Alberto Núñez, Pilar Sobrino, Victoria Espejo, Lucía Fabia, Lydia Vela, et al. (+2)
160 [GO] 2020―Jun―08 Ovarian vein thrombosis after coronavirus disease (COVID-19) infection in a pregnant woman: case report Susan Mohammadi, Morteza Abouzaripour, Nastaran Hesam Shariati, Mohammad Bakhtiar Hesam Shariati
161 [GO] 2020―Jun―06 Hyperacute multi-organ thromboembolic storm in COVID-19: a case report Sarah Chibane, Guillaume Gibeau, Frédéric Poulin, Pierre Tessier, Michelle Goulet, Marc Carrier, Sylvain Lanthier
162 [GO] 2020―Jun―05 Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients Anna Betoule, Camille Martinet, Guillaume Gasperini, Pauline Muller, Stéphane Foucher, Patrick Benner, Aurélien Renard
163 [GO] 2020―May―31 The association between treatment with heparin and survival in patients with Covid-19 Luis Ayerbe, Carlos Risco, Salma Ayis
164 [GO] 2020―May―30 Global haemostatic tests in rapid diagnosis and management of COVID-19 associated coagulopathy in acute limb ischaemia Bingwen Eugene Fan, Yew Woon Chia, Christina Lai Lin Sum, Ponnudurai Kuperan, Stephrene Seok Wei Chan, Li Min Ling, et al. (+10)
165 [GO] 2020―May―30 Acute pulmonary embolism in COVID-19 related hypercoagulability Cerruti Lorenzo, Boscaro Francesca, Poletto Francesco, Campello Elena, Spiezia Luca, Simioni Paolo
166 [GO] 2020―May―25 Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors Mathieu Artifoni, Gwenvael Danic, Giovanni Gautier, Pascal Gicquel, David Boutoille, François Raffi, et al. (+2)
167 [GO] 2020―May―22 Heparin resistance in COVID-19 patients in the intensive care unit D. White, S. MacDonald, T. Bull, M. Hayman, R. de Monteverde-Robb, D. Sapsford, et al. (+5)
168 [GO] 2020―May―21 Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum Geoffrey D. Barnes, Allison Burnett, Arthur Allen, Marilyn Blumenstein, Nathan P. Clark, Adam Cuker, et al. (+6)
169 [GO] 2020―May―19 Toward understanding the 2019 Coronavirus and its impact on the heart Richard C. Becker
170 [GO] 2020―May―16 Correction to: Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies and the lack of guidelines Angelo Porfidia, Roberto Pola
171 [GO] 2020―May―15 COVID-19 update: Covid-19-associated coagulopathy Richard C. Becker
172 [GO] 2020―May―11 Sudden death due to acute pulmonary embolism in a young woman with COVID-19 Veli Polat, Güngör İlayda Bostancı
173 [GO] 2020―May―11 Fibrinolysis in COVID-19 patients with hemodynamic unstable acute pulmonary embolism: yes or no? Loris Roncon, Marco Zuin, Pietro Zonzin
174 [GO] 2020―May―11 Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia Vittorio Pavoni, Lara Gianesello, Maddalena Pazzi, Caterina Stera, Tommaso Meconi, Francesca Covani Frigieri
175 [GO] 2020―May―05 Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy F. Burcu Belen-Apak, F. Sarıalioğlu
176 [GO] 2020―May―04 Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies Angelo Porfidia, Roberto Pola
177 [GO] 2020―Apr―27 Covid-19 treatment update: follow the scientific evidence Richard C. Becker
178 [GO] 2020―Apr―18 Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report Bo Zhou, Jianqing She, Yadan Wang, Xiancang Ma
179 [GO] 2020―Apr―03 Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 Shiyu Yin, Ming Huang, Dengju Li, Ning Tang

179 Results       Page 1


Last change 2023―Apr―13 19:50:14 UTC

© Daten-Quadrat 2022       Done in 0.005 sec